They further found that granzyme C-expressing ILC1s expanded in mammary tumors and can mediate anti-tumor responses, a mechanism dependent on transforming growth factor beta (TGF-β) and IL-15 signaling [45]. The gene discussed is TGFB1; the disease is neoplasm.